Testing effectiveness (Phase 2)Study completedNCT01757613
What this trial is testing
Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
Who this might be right for
Actinic Keratosis Olsen Grade I/II
Dolorgiet GmbH & Co. KG 150